Khan Najat 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed Aug 5, 2024
Insider Transaction Report
Form 4
Khan Najat
DirectorCEO and President
Transactions
- Award
Class A Common Stock
2024-08-01+496,972→ 496,972 total - Award
Stock Option (Right to Buy)
2024-08-01+993,944→ 993,944 totalExercise: $7.34Exp: 2034-08-01→ Class A Common Stock (993,944 underlying)
Footnotes (2)
- [F1]This RSU vests as to one fourth (1/4th) of the units subject to the RSU on August 15, 2025 and one sixteenth (1/16th) every three months thereafter subject to Reporting Person's continued service to the Issuer through each such vesting date.
- [F2]This option vests as to one fourth (1/4th) of the shares subject to the option on July 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter subject to Reporting Person's continued service to the Issuer through each such vesting date.